RxDoctor Payments Data

Christine White, DO

Family Medicine · Blue Springs, MONPI 1881210250

Payments from drug & device makers

$2,807in general payments, 2019–2025

Across 154 payments — averaging $18.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$590
  • Lilly USA, LLC$284
  • Pfizer$273
  • AstraZeneca$270
  • Novo Nordisk$222
  • Abbott$122
  • plus $1K from 27 others

What the payments were for

  • Food & beverage$2,807100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,807 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$59,614
Medicare patients
217
Services billed
633

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide27$31,188
OzempicSemaglutide18$26,060
Tresiba Flextouch U-200Insulin Degludec18$11,360
MyrbetriqMirabegron23$10,835
Janumet XrSitagliptin Phos/Metformin Hcl11$8,263
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$7,159
Humalog Kwikpen U-100Insulin Lispro12$5,047
ArexvyRsvpref3 Antigen/As01e/Pf14$3,418
Gabapentin139$2,341
Omeprazole126$1,937
Losartan Potassium123$1,420
Fentanyl13$1,216
Duloxetine Hcl65$1,173
Atorvastatin Calcium125$1,036
Albuterol Sulfate HfaAlbuterol Sulfate56$989

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$284$31,18827 claims
Novo NordiskOzempic$222$26,06018 claims
Astellas Pharma US IncMyrbetriq$70$10,83523 claims
GSKTrelegy Ellipta, Arexvy$117$10,57725 claims
AbbVieSynthroid$590$76412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Blue Springs

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →